These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 145758)

  • 21. Targeting of liposomes containing methotrexate towards Tetrahymena pyriformis cells.
    Kotsifaki H; Kapoulas V; Deliconstantinos G
    Gen Pharmacol; 1985; 16(6):573-7. PubMed ID: 3936748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retention and distribution of liposome-entrapped [3H]methotrexate injected into normal or arthritic rabbit joints.
    Foong WC; Green KL
    J Pharm Pharmacol; 1988 Jul; 40(7):464-8. PubMed ID: 2904984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of the humoral response of intravenous antigen by splenotropic liposomes.
    Liu DX; Wada A; Huang L
    Immunol Lett; 1992 Feb; 31(2):177-81. PubMed ID: 1740352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of free and liposome-entrapped [3H]methotrexate in the central nervous system after intracerebroventricular injection in a primate.
    Kimelberg HK; Tracy TF; Watson RE; Kung D; Reiss FL; Bourke RS
    Cancer Res; 1978 Mar; 38(3):706-12. PubMed ID: 414833
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.
    Rahman A; White G; More N; Schein PS
    Cancer Res; 1985 Feb; 45(2):796-803. PubMed ID: 3967247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment.
    Srisuk P; Thongnopnua P; Raktanonchai U; Kanokpanont S
    Int J Pharm; 2012 May; 427(2):426-34. PubMed ID: 22310459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue distribution of EDTA encapsulated within liposomes of varying surface properties.
    Jonah MM; Cerny EA; Rahman YE
    Biochim Biophys Acta; 1975 Sep; 401(3):336-48. PubMed ID: 810161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomes as carriers in vivo for methotrexate.
    Colley CM; Ryman BE
    Biochem Soc Trans; 1975; 3(1):157-9. PubMed ID: 1168593
    [No Abstract]   [Full Text] [Related]  

  • 29. Preparation and prolonged tissue retention of liposome-encapsulated chelating agents.
    Rahman YE; Rosenthal MW; Cerny EA; Moretti ES
    J Lab Clin Med; 1974 Apr; 83(4):640-7. PubMed ID: 4206355
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacokinetics of dihydrostreptomycin, after intravenous administration as a liposomal preparation, in the blood serum and tissues of intact mice and those with generalized tuberculosis].
    Vladimirskiĭ MA; Ladygina GA; Stepanov VM
    Antibiotiki; 1984 Apr; 29(4):282-5. PubMed ID: 6204583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of liposome-entrapped mannitol by diaphragm.
    Nakatsu K; Cameron DA
    Can J Physiol Pharmacol; 1979 Jul; 57(7):756-9. PubMed ID: 487285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution and degradation of [3H]methotrexate after intravenous and cerebral intraventricular injection in primates.
    Kimelberg HK; Biddlecome SM; Bourke RS
    Cancer Res; 1977 Jan; 37(1):157-65. PubMed ID: 401470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of vesicle size on the clearance, distribution, and tumor uptake of temperature-sensitive liposomes.
    Magin RL; Hunter JM; Niesman MR; Bark GA
    Cancer Drug Deliv; 1986; 3(4):223-37. PubMed ID: 3567843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery.
    Poste G; Bucana C; Raz A; Bugelski P; Kirsh R; Fidler IJ
    Cancer Res; 1982 Apr; 42(4):1412-22. PubMed ID: 7060015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting of methotrexate-containing liposomes with a monoclonal antibody against human renal cancer.
    Singh M; Ghose T; Faulkner G; Kralovec J; Mezei M
    Cancer Res; 1989 Jul; 49(14):3976-84. PubMed ID: 2660984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation.
    Sadarani B; Majumdar A; Paradkar S; Mathur A; Sachdev S; Mohanty B; Chaudhari P
    Biomed Pharmacother; 2019 Jun; 114():108770. PubMed ID: 30913494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain, liver and spleen detection of liposomes after rectal administration.
    Gabev EE; Svilenov DK; Poljakova-Krusteva OT; Vassilev I
    J Microencapsul; 1985; 2(2):85-9. PubMed ID: 3880482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of entrapment in liposomes on the distribution, degradation and effectiveness of methotrexate in vivo.
    Kimelberg HK; Atchison ML
    Ann N Y Acad Sci; 1978; 308():395-410. PubMed ID: 100041
    [No Abstract]   [Full Text] [Related]  

  • 39. Tissue distribution of methotrexate in rats. A comparison between intravenous injection as bolus or drip infusion.
    Miglioli PA; Businaro V; Manoni F; Berti T
    Drugs Exp Clin Res; 1985; 11(4):275-9. PubMed ID: 3836130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved skin permeation of methotrexate via nanosized ultradeformable liposomes.
    Zeb A; Qureshi OS; Kim HS; Cha JH; Kim HS; Kim JK
    Int J Nanomedicine; 2016; 11():3813-24. PubMed ID: 27540293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.